Evidence map›Paper›PMID 39268485›Full record

ArticleFrontiers in cellular and infection microbiology2024

Development and validation of next-generation sequencing panel for personalized

Byung-Joo Min, Myung-Eui Seo, Jung Ho Bae, Ji Won Kim, Ju Han Kim

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. CurrentJGH open : an open access journal of gastroenterology and hepatology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Byung-Joo Min *Forensic DNA Division, National Forensic Service Seoul Institute, Seoul, Republic of Korea.
Myung-Eui Seo *Seoul National University Biomedical Informatics (SNUBI), Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jung Ho BaeDepartment of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Republic of Korea.
Ji Won KimDepartment of Internal Medicine, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Ju Han KimSeoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The decreasing Method: A custom next-generation sequencing panel for personalized Results: Both previously reported and novel variants were identified from Discussion: Applying the methodology using the NGS-PHET and customized framework helps to perform eradication treatment quickly and effectively in most patients with antibiotic-resistant

Indexed as

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriHigh-Throughput Nucleotide SequencingPrecision MedicineAdultAmoxicillinClarithromycinCytochrome P-450 CYP2C19Drug Resistance, BacterialDrug Therapy, CombinationFemaleHumansLevofloxacinMaleMetronidazoleAmoxicillinAnti-Bacterial AgentsClarithromycinCytochrome P-450 CYP2C19LevofloxacinMetronidazoleProton Pump InhibitorsTetracyclineantibiotic resistanceindividual antibiotic resistance profilemultispecies integrated next-generation sequencing panelpersonalized Helicobacter pylori eradication treatmentproton-pump inhibitor metabolic phenotype

Identifiers

PMID39268485
PMCPMC11390507

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.